Matches in Wikidata for { <http://www.wikidata.org/entity/Q56608513> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q56608513 description "article by Jonathan W. Goldman et al published January 2016 in Clinical Lung Cancer" @default.
- Q56608513 description "article scientifique publié en 2016" @default.
- Q56608513 description "artículu científicu" @default.
- Q56608513 description "im Januar 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56608513 description "wetenschappelijk artikel" @default.
- Q56608513 description "наукова стаття, опублікована в січні 2016" @default.
- Q56608513 name "Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS" @default.
- Q56608513 name "Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS" @default.
- Q56608513 type Item @default.
- Q56608513 label "Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS" @default.
- Q56608513 label "Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS" @default.
- Q56608513 prefLabel "Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS" @default.
- Q56608513 prefLabel "Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS" @default.
- Q56608513 P1433 Q56608513-7F00D6E8-EC68-4562-BC25-E75FCEF9EEC3 @default.
- Q56608513 P1476 Q56608513-A54788E1-3CF9-4820-B54F-89EFEF89936E @default.
- Q56608513 P2093 Q56608513-0142FBFA-9DD6-417B-B479-3532B1621F16 @default.
- Q56608513 P2093 Q56608513-0F4A5EFF-F652-4B68-BA8E-593687036E27 @default.
- Q56608513 P2093 Q56608513-59479E3B-007A-4658-B318-0A67C5B075A2 @default.
- Q56608513 P2093 Q56608513-7586F411-871B-494D-AD7A-F8B82D0D045D @default.
- Q56608513 P2093 Q56608513-9A95CB84-2ECA-4515-8DFD-567C038DDA80 @default.
- Q56608513 P2093 Q56608513-DAB1B70B-92E6-4F0F-A3DE-AEFBBFD7E52F @default.
- Q56608513 P304 Q56608513-71EA7807-B378-4F51-8071-4D00E54E7A64 @default.
- Q56608513 P31 Q56608513-D4E167F5-CC90-4444-B605-85C97AB5E005 @default.
- Q56608513 P356 Q56608513-182DFE2E-752E-444B-A56D-A4FB2AA2D2ED @default.
- Q56608513 P407 Q56608513-0E6ED4DC-B50E-4572-96BC-FE1FAA8B6D6D @default.
- Q56608513 P433 Q56608513-A428E841-6CE8-489C-A56C-CBC1B7EEF192 @default.
- Q56608513 P478 Q56608513-F4C95DB9-2EF0-4A64-8070-AFEBEC16E4B6 @default.
- Q56608513 P577 Q56608513-97425795-34C1-48FC-931D-CC0FC1935973 @default.
- Q56608513 P698 Q56608513-AEC40123-2776-4B53-9906-E76F176DE44B @default.
- Q56608513 P921 Q56608513-3C5153E2-2BCA-45BD-A4AF-4E44999EFBA2 @default.
- Q56608513 P356 J.CLLC.2015.08.003 @default.
- Q56608513 P698 26432508 @default.
- Q56608513 P1433 Q332299 @default.
- Q56608513 P1476 "Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS" @default.
- Q56608513 P2093 "Andrew Koustenis" @default.
- Q56608513 P2093 "Jonathan W. Goldman" @default.
- Q56608513 P2093 "Karla C. Hurt" @default.
- Q56608513 P2093 "Luis Paz-Ares" @default.
- Q56608513 P2093 "Martin Reck" @default.
- Q56608513 P2093 "Peipei Shi" @default.
- Q56608513 P304 "80-84" @default.
- Q56608513 P31 Q13442814 @default.
- Q56608513 P356 "10.1016/J.CLLC.2015.08.003" @default.
- Q56608513 P407 Q1860 @default.
- Q56608513 P433 "1" @default.
- Q56608513 P478 "17" @default.
- Q56608513 P577 "2016-01-01T00:00:00Z" @default.
- Q56608513 P698 "26432508" @default.
- Q56608513 P921 Q47912 @default.